The functions of palmitate turnover in signal transduction are poorly understood. Results: Inhibiting palmitate turnover on R7BP redistributed R7BP-R7 RGS complexes from the plasma membrane to endomembranes, dissociated them from GIRK channels, and delayed G i/o deactivation and channel closure. Conclusion: Palmitate turnover on R7BP promotes GIRK channel deactivation. Significance: Inhibiting palmitate turnover on R7BP could enhance GIRK activity in neurological disorders.
Palmitoylation (S-palmitoylation or S-acylation) is a posttranslational modification of proteins in which palmitate or other long-chain fatty acids are attached via thioester linkage to cysteine residues (1, 2) . Hundreds of proteins in eukaryotic cells, including monomeric and heterotrimeric G proteins, G protein-coupled receptors, ion channels, regulatory enzymes, and scaffold proteins are palmitoylated. Palmitoylation has diverse functions, including anchoring hydrophilic proteins to membranes, sorting proteins into membrane lipid microdomains, and regulating intracellular protein trafficking, proteinprotein interactions, and degradation. Indeed, palmitoylation has important roles in several diseases, including cancer, Huntington disease, and neuronal ceroid lipofuscinosis (3) (4) (5) (6) .
Unlike other lipid modifications, palmitoylation is reversible under physiological conditions. Palmitate is attached to proteins by palmitoyltransferases bearing a conserved Asp-His-His-Cys (DHHC) motif and removed by acylprotein thioesterases of the serine hydrolase superfamily (1, 2, (7) (8) (9) (10) . Being reversible, palmitoylation is widely hypothesized, like phosphorylation, to regulate protein function (1, 11, 12) . Indeed, palmitate turnover rates on proteins range from minutes (e.g. H-and N-Ras (13, 14) ) to hours (e.g. SNAP-25 (15) ), and the palmitoylation status of many proteins is altered in response to cell activation (11, 12, 16 -20) .
Despite such evidence, whether palmitate turnover provides a regulatory switch that controls protein function remains a central question. This concept is best supported by studies of palmitoylated Ras isoforms. Inhibiting depalmitoylation with palmostatin B, a small molecule designed to inhibit acylprotein thioesterase 1 (APT1), 3 redistributes H-or N-Ras from the plasma membrane to endomembrane compartments and blunts growth factor-evoked activation of Ras on the Golgi apparatus (7) . These and other findings have indicated that H/N-Ras is depalmitoylated globally by acylprotein thioesterases, repalmitoylated by endomembrane-localized palmitoyltransferases, and then delivered for anterograde transport to the plasma membrane (21) . A variant of this model in which palmitoylation occurs both on endomembranes and the plasma membrane has been suggested by studies of the dynamically palmitoylated postsynaptic scaffold protein PSD-95 (18) . Proteomic analysis using alkynyl palmitate analogs and pulse-chase analysis has confirmed these findings, identifying a subset of enzymatically regulated palmitoylated proteins in mouse T-cells, including Ras family GTPases, subunits of heterotrimeric G proteins (including G s ␣ and G 13 ␣), membrane-associated guanylate kinases, leucine-rich repeat and PDZ domain (LAP) proteins, and other cancer-related scaffolding proteins (22) .
Whereas dynamic palmitoylation occurs on select proteins, many important questions remain because the functional consequences of depalmitoylation are nearly completely unknown. How widely is palmitate turnover, as distinguished from palmitoylation per se, required for function or regulation of specific, palmitoylated proteins? What mechanisms determine whether palmitate turnover occurs rapidly or slowly on palmitoylated proteins? Does regulated palmitate turnover serve as a switch to control protein function?
To elucidate functions of palmitate turnover in neuronal G protein-coupled receptor signaling, we have studied the regulator of G-protein signaling 7 (R7 RGS) family (RGS6, -7, -9 -1, -9 -2, and -11) and its control by R7 RGS-binding protein (R7BP), a hydrophilic, palmitoylated SNARE-like protein (23) . R7 RGS proteins form obligate heterodimers with G␤5 and function as GTPase-activating proteins that accelerate deactivation of G i/o class G␣ subunits (24, 25) . When activated allosterically upon association with R7BP, R7 RGS-G␤5 complexes assemble with G protein-regulated inwardly rectifying K ϩ (GIRK) channels to facilitate G i/o deactivation and consequent channel closure (26) . Palmitoylation is required for localizing R7BP to the plasma membrane, whereas palmitoylation blockade results in transport of R7BP into the nucleus (27) . At steady state, palmitate turnover occurs rapidly on R7BP, which can be negatively regulated by G i/o signaling (28) . Accordingly, palmitate turnover on R7BP may provide a mechanism to regulate GIRK activity evoked by G i/o -coupled receptors. Here, we have tested this hypothesis by analyzing the consequences of inhibiting the rate-limiting depalmitoylation step of palmitate turnover on R7BP trafficking and function. Our studies identify a novel function for palmitate turnover in neuronal cell signaling.
EXPERIMENTAL PROCEDURES
Vertebrate Animals-All experimental protocols involving vertebrate animals were approved by the Animal Studies Committee at Washington University.
Cell Culture and Transfection-Neuro2A cells endogenously expressing RGS7 and G␤5 but not R7BP, Neuro2A cells stably transfected with FLAG-R7BP, and HEK293T cells were cultured as described previously (28, 29) . Cells were transfected with Lipofectamine 2000 (Invitrogen) according to the supplier's recommendations. Cells were treated with DMSO, palmostatin B (Palm B), hexadecyl fluorophosphonate (HDFP), and/or cycloheximide (Sigma), in Opti-MEM (Invitrogen) at 37°C unless otherwise noted. Neuro2A cells stably transfected with the APT1 knockdown plasmid pLKO.1-APT1 were selected and maintained under puromycin selection. Hippocampal neurons were isolated from wild type and R7BP Ϫ/Ϫ mice as described previously (28) . Neurons were cultured for 14 days (days in vitro 14) before drug treatment and electrophysiological recording.
Reagents and Antibodies-The following antibodies were used: mouse anti-GFP (Abcam); rabbit anti-GFP-Sepharose beads (Abcam); mouse monoclonal anti-FLAG M2 (Sigma); mouse anti-FLAG M2 beads (Sigma); mouse anti-GS28 (BD Transduction Laboratories); goat anti-mouse IR800 and goat anti-rabbit IR 680 (LI-COR); and AlexaFluor 488-labeled goat anti-rabbit IgG and AlexaFluor 568-labeled goat anti-mouse IgG (Invitrogen). Affinity-purified rabbit and chicken polyclonal anti-R7BP antibodies have been described previously (29) . Other reagents were as follows: palmostatin B (C. Hedberg, Max Planck Institute, Dortmund, Germany); Renilla luciferase substrate coelenterazine-h (Nanolight Technology); EDTA-free complete protease inhibitor mixture tablets (Roche Applied Science); D-2-amino-5-phosphonovalerate and 2,3dihydroxy-6-nitro-7-sulfonyl-benzo[f]quinoxaline (Tocris); tetramethylrhodamine (TAMRA)-azide (Lumiprobe); and 17-octadecynoic acid (17-ODYA) (Cayman Chemical Co.). The following chemicals were obtained from Sigma: DMSO, cycloheximide, phenylmethylsulfonyl fluoride (PMSF), poly-D-lysine, tris(2-carboxyethyl)phosphine hydrochloride, tris-(benzyltriazolylmethyl)amine, CuSO 4 , and puromycin.
Plasmids-Plasmids expressing GFP-tagged R7BP, RFPtagged R7BP, split Venus(1-555)-tagged RGS9, and split Venus(156 -239)-tagged G␤5 have been published previously (26) . Sources of other plasmids expressing various proteins were as follows: GFP-N-Ras and GFP-SNAP25 (M. Linder, Cornell University); RFP-Rab5 (P. Stahl, Washington University); GABA B receptor subunits 1a and 2 (B. Bettler, University of Basel, Basel, Switzerland), and GIRK2c (P. Slesinger, Salk Institute). Plasmids expressing GFP-tagged geranylgeranylated R7BP and FLAG-tagged geranylgeranylated R7BP were generated by replacing the wild type R7BP coding sequence for the C-terminal peptide LCCLVSS with a sequence coding for CLIL. Plasmids expressing constitutively active and RGS-resistant G o ␣ was made by replacing coding sequences for Gln-209 to Leu and Gly-182 to Ser using site-directed mutagenesis. The mouse APT1 and APT2 cDNAs were inserted into pEGFP-C1 plasmids to express GFP-APT1 and -APT2. The knockdown targeting sequence in pLKO.1-APT1 for mouse APT1 was GCATTCCTTCTAACAGGATTA. The control knockdown targeting sequence in pLKO.1-Luc for luciferase was GCT-GAGTACTTCGAAATGTCC. Duplex RNAs used to knock down APT2 were AGCUCCGGACUGUUGUCACACCUGC and GCAGGUGUGACAACAGUCCGGAGCUUC. All plasmids were verified by DNA sequencing.
Fluorescence Confocal Microscopy-Neuro2A cells seeded on poly-D-lysine (10 g/ml)-coated coverslips were transfected with indicated plasmids. At 24 h post-transfection, cells were treated 4 -6 h as indicated and fixed with paraformaldehyde (4%) for 10 min at room temperature. Cells were mounted in VECTASHIELD mounting medium (Vector Laboratories), and fluorescence images at different wavelengths were captured sequentially on an Olympus FV500 microscope using Fluoroview software. Images were adjusted for brightness and contrast, assembled as montage, and analyzed using ImageJ software.
Metabolic Labeling, Immunoprecipitation, and On-Bead Click Chemistry-Neuro2A cells stably expressing FLAG-R7BP or transiently expressing GFP-N-Ras and GFP-SNAP25 were labeled with 25 M 17-ODYA for 2 and 6 h for GFP-SNAP25 in DMEM (Invitrogen) supplemented with 5% dialyzed FBS, 0.1 mM sodium pyruvate, and 0.1 mM nonessential amino acids. Cells were washed with phosphate-buffered saline (PBS) prior to being chased with media containing 200 M palmitate in the presence of either vehicle (DMSO), Palm B, or HDFP for the indicated periods of time. Cells were then washed and suspended in lysis buffer (PBS supplemented with 2.5 M PMSF, 1ϫ EDTA-free Complete Protease Inhibitors, and 1% Triton X-100). Cleared lysates were immunoprecipitated overnight at 4°C with mouse anti-FLAG beads or rabbit anti-GFP beads. After three washes with lysis buffer, beads were suspended in PBS. Click chemistry reaction protocols were adopted from previous publications (30, 31) . Immunoprecipitated samples were reacted with click chemistry reagents (20 M TAMRAazide, 1 mM tris(2-carboxyethyl)phosphine hydrochloride, 100 M tris-(benzyltriazolylmethyl)amine, and 1 mM CuSO 4 ) for 1 h at room temperature with periodic mixing. Reactions were stopped by addition of reducing SDS-PAGE sample buffer and boiling for 5 min at 100°C. Samples were separated by SDS-PAGE and analyzed by in-gel fluorescence analysis (Typhoon 9400 laser scanner, GE Healthcare) and Western blotting. Bands of interest were quantified using ImageJ (TAMRA fluorescence) or ImageLab (Western blotting) software under conditions where detection was demonstrated by control experiments to be in the linear range.
Electrophysiology-Patch clamp recordings were performed in whole-cell mode using an Axopatch 200B amplifier (Molecular Devices) at room temperature. Experiments were conducted with cultured hippocampal neurons 11-13 days after plating, as described previously (26, 32) , and in transfected Neuro2A cells. Primary neurons and Neuro2A cells were transferred from culture medium to an extracellular recording solution containing (in mM) the following : 138 NaCl, 4 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, 0.001 2,3-dihydroxy-6nitro-7-sulfonyl-benzo[f]quinoxaline, 0.01 D-2-amino-5-phosphonovalerate, and 0.01 SR-95531 (gabazine) or 0.01 bicuculline at pH 7.25. Patch pipettes (4 -6 megohms) were filled with a solution containing (in mM) the following: 115 K ϩ gluconate, 20 KCl, 2 EGTA, 10 HEPES, 2 Mg 2ϩ -ATP, and 0.3 Na-GTP at pH 7.25. Cells were clamped at Ϫ70 mV, and access resistance (8 -12 megohms) was not compensated. GIRK currents were evoked by GABA B receptor activation with baclofen (50 M). GIRK current was recorded in high K ϩ solution with the following composition (in mM): 84 NaCl, 60 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, 0.001 2,3-dihydroxy-6-nitro-7sulfonyl-benzo[f]quinoxaline, 0.01 D-2-amino-5-phosphonovalerate, and 0.01 SR-95531 at pH 7.25. In these conditions, driving force on K ϩ yielded inward current at the holding potential of Ϫ70 mV. Solutions and drugs were applied with a multibarrel, gravity-driven local perfusion system. The esti-mated solution exchange times were 120 Ϯ 14 ms (10 -90% rise time), measured by the change in junction currents at the tip of an open patch pipette. Where indicated, plasmids expressing GFP-tagged wild type R7BP or R7BP-GG were transfected into Neuro2A cells 24 h before electrophysiology experiments. Data acquisition and analysis were performed with pCLAMP 9.2 software (Molecular Devices). Data were processed with Microsoft Excel and presented as mean Ϯ S.E. Statistical differences were determined using Student's two-tailed unpaired t test. Offset decay times were measured using standard exponential fitting functions. Data plotting, statistical analysis, and figure preparations were completed with Prism 5.01 software (GraphPad), and Adobe Photoshop.
Bioluminescence Resonance Energy Transfer (BRET)-Measurement of BRET in intact cells between GIRK2c-Rluc8 and split Venus-tagged R7-RGS-G␤5 complexes was performed as described previously (26) . As indicated, cells also were co-transfected with a plasmid expressing FLAG-tagged R7BP. The results are expressed as means Ϯ S.E. Statistical comparisons between groups were done using Student's t test.
Activity-based Labeling of APT1 and APT2-Neuro2A cells were transfected with plasmids expressing GFP, GFP-APT1, or GFP-APT2, lysed by sonication, treated 30 min with or without reversible APT1-and APT2-selective inhibitors (compounds 21 and 1, 10 M each(33)), and probed with an activity-dependent fluorescent probe (PEGylated rhodamine-labeled fluorphosphonate) for 10 min at room temperature (33) . Activitydependent labeling of GFP-APT1 or -APT2 resolved by SDS-PAGE was quantified by fluorescence scanning normalized to the level of expressed protein determined by quantitative immunoblotting (LI-COR).
RESULTS
Inhibition of Palmitate Turnover on R7BP-Because our prior studies showed that R7BP undergoes palmitate turnover (28), we investigated the functions of this process by using Palm B or HDFP to inhibit APT1 and other enzymes in the serine hydrolase family that mediate protein depalmitoylation (9, 22, 34) . Because HDFP and Palm B are globally acting irreversible inhibitors of depalmitoylation, and Palm B can covalently modify proteins in addition to serine hydrolases (9), the experiments described below employed extensive controls to determine the specificity of effects observed.
First, we used established methods (20, 31) to measure the depalmitoylation rate of FLAG-tagged R7BP expressed stably at physiological levels with endogenous RGS7-G␤5 complexes in neuroblastoma (Neuro2A) cells (29) . Control, Palm B-, or HDFP-treated cells were pulse-labeled with the palmitate analog 17-ODYA, chased with conventional palmitate, and lysed at various time points. After immunoprecipitation, 17-ODYA-labeled proteins were conjugated with an azide-linked fluorescent dye (TAMRA) by using click chemistry. TAMRA-labeled FLAG-R7BP was quantified relative to total FLAG-R7BP. TAMRA labeling of FLAG-R7BP during the chase indicated the rate and extent of depalmitoylation in cells.
The results indicated that FLAG-R7BP is depalmitoylated by mechanisms sensitive to Palm B or HDFP (Fig. 1) . In control cells, FLAG-R7BP was depalmitoylated ϳ70% within 1 h (Fig.  1A ), consistent with prior [ 3 H]palmitate pulse-chase labeling studies (28) . Palm B or HDFP inhibited depalmitoylation of FLAG-R7BP in a dose-dependent manner (Fig. 1A) . Pulsechase analysis indicated that HDFP (10 M) slowed the depalmitolyation rate of FLAG-R7BP ϳ5-fold ( Fig. 1B) . Likewise, depalmitoylation of transiently expressed GFP-tagged N-Ras was markedly inhibited by HDFP (Fig. 1C) . In contrast, transiently expressed GFP-SNAP25 did not undergo significant depalmitoylation within 2 h with or without HDFP, consistent with prior evidence indicating that palmitate turnover on this protein occurs slowly (19, 35) . These results indicated that Palm B and HDFP inhibit depalmitoylation of proteins that undergo rapid palmitate turnover.
Palmitate Turnover Is Required for Localizing R7BP to the Plasma Membrane-Because models based on studies of H/N-Ras indicate that palmitate turnover is required for localizing palmitoylated hydrophilic proteins to the plasma membrane (21), we analyzed the effects of Palm B and HDFP on the subcellular localization of R7BP. Neuro2A cells transfected with GFP-R7BP were treated with cycloheximide to block new protein synthesis, incubated 2 h with vehicle, Palm B, or HDFP, and then fixed and analyzed by confocal fluorescence microscopy. In control cells, GFP-R7BP localized primarily to the plasma membrane and to a lesser extent on endomembranes (Fig. 2) , similar to endogenous R7BP in neurons (29) . Following Palm B or HDFP treatment in the presence of cycloheximide, pre-existing GFP-R7BP was depleted from the plasma membrane and accumulated on endomembrane compartments overlapping with Golgi (Fig. 2, A and B) and endosome (Fig. 2C ) markers, indicating that redistribution had occurred. Redistribution of pre-existing GFP-R7BP following Palm B or HDFP administration was confirmed by time-lapse fluorescence confocal microscopy (Fig. 2D) . Palm B and HDFP had similar effects on FLAG-R7BP stably expressed in Neuro2A cells at physiological levels ( Fig. 2E) . Palm B and HDFP increased the extent that RFP-R7BP and GFP-N-Ras co-localized on endomembrane compartments (Fig. 2F) , indicating that inhibition of palmitate turnover affects the trafficking of these proteins similarly. In contrast, under the same conditions Palm B or HDFP did not affect the localization of GFP-SNAP-25 (Fig. 2G ) or a form of GFP-R7BP in which its C-terminal polybasic region was preserved but its palmitoylation sites (CCLVSS) were replaced with the irreversible lipid modification (geranylgeranyl) motif (CLIL) of RhoA (GFP-R7BP-GG; Fig. 2H ). Furthermore, HDFP and Palm B did not impair cell viability or organelle (Golgi, endosome) distribution or identity. Therefore, Palm B and HDFP had the specific effect of causing proteins that undergo palmitate turnover to redistribute from the plasma membrane to endomembranes.
The time course of R7BP redistribution (t1 ⁄ 2 ϳ60 min) elicited by Palm B or HDFP was similar to that shown previously for N-Ras in Palm B-treated cells (7) but much slower than the intrinsic rate that palmitoylated proteins translocate to endomembranes (seconds to minutes (36) ). Presumably, redistribution kinetics of R7BP or Ras reflect the relatively slow rate that 
Palm B or HDFP enters cells and inactivates serine hydrolases sufficiently to inhibit depalmitoylation globally.
Because prior studies showed that constitutively active G o ␣ inhibits R7BP depalmitoylation in Neuro2A cells (28), we determined whether expression of a constitutively active G o ␣ mutant that does not bind RGS proteins (G o ␣*; G o ␣-Q205L/ G184S) affected R7BP localization. Indeed, G o ␣* caused GFP-R7BP to accumulate on endomembrane compartments (Fig.  2I) , indicating that R7BP depalmitoylation and intracellular trafficking can be regulated by activated G o ␣ by a mechanism independent of RGS-G␣ interaction.
Palmitate Turnover on R7BP Regulates Trafficking and Function of R7 RGS-G␤5 Complexes-Because R7BP associates with R7 RGS⅐G␤5 complexes (27) , we next determined whether palmitate turnover regulates the trafficking of R7 RGS-G␤5-R7BP heterotrimers. Split Venus-tagged forms of the R7 RGS protein RGS9-2 and G␤5 were co-expressed transiently with RFP-R7BP in Neuro2A cells. In control cells these proteins colocalized extensively on the plasma membrane, whereas in HDFP-treated cells they co-localized on endomembrane compartments (Fig. 2J) . Because RGS9-2⅐G␤5 complexes expressed transiently without R7BP localized diffusely to the cytoplasm and nucleoplasm (27) , the effects of Palm B and HDFP indicated that inhibiting palmitate turnover on R7BP redistributes RGS9-2-G␤5-R7BP heterotrimers from the plasma membrane to endomembranes.
To address whether palmitate turnover is required for the function of R7 RGS⅐G␤5⅐R7BP complexes, we determined whether HDFP affects the ability of R7BP to allosterically modulate R7 RGS⅐G␤5 complexes. This allosteric mechanism facilitates association of R7 RGS⅐G␤5 complexes with GIRK channels, as indicated by BRET experiments using cells co-expressing luciferase-tagged GIRK2c as donor and split Venustagged forms of R7 RGS proteins and G␤5 as acceptors (26) . Consistent with prior studies, FLAG-R7BP augmented BRET between GIRK2c and RGS9-2-G␤5 heterodimers ϳ5-fold relative to controls lacking R7BP (Fig. 3A) . HDFP significantly reduced BRET in R7BP-expressing cells (Fig. 3A) but did not affect BRET between GIRK2c and RGS9-2-G␤5 heterodimers in cells lacking R7BP.
Next, we determined whether HDFP affects R7BP-dependent regulation of GIRK channel activity by R7 RGS⅐G␤5 complexes in cultured hippocampal pyramidal neurons. GIRK channels are opened by G␤␥ subunits and closed by channelbound G i/o ␣ subunits that have hydrolyzed GTP to GDP and reformed G␣␤␥ heterotrimers (37, 38) . By accelerating G i/o ␣- mediated GTP hydrolysis, R7 RGS-G␤5 complexes recruited to GIRK channels by R7BP facilitate channel closure (26) . Accordingly, we treated hippocampal neurons from wild type and R7BP Ϫ/Ϫ mice with vehicle or HDFP and recorded whole-cell GIRK currents in response to application and subsequent washout of baclofen, a GABA B receptor agonist. Ablating R7BP or treating wild type neurons with HDFP impaired GIRK current deactivation kinetics (offset) similarly (Fig. 3, B and C) . In R7BP Ϫ/Ϫ neurons, however, HDFP had a nonsignificant effect on GIRK current deactivation (Fig. 3, B and C) . Because these results indicated that HDFP requires the presence of R7BP to affect GIRK current deactivation, they suggested that palmitate turnover on R7BP is essential for R7 RGS⅐G␤5 complexes to regulate GIRK channel activity.
Whereas R7BP is required for HDFP to affect GIRK channel deactivation, we used a further approach to establish whether HDFP exerts its effects specifically by inhibiting depalmitoylation of R7BP rather than other proteins in this system such as G i/o ␣ subunits that also undergo palmitate turnover (39, 40) . We determined whether R7BP bearing a polybasic region and geranylgeranylation motif (R7BP-GG) is functional and resistant to HDFP as assessed by the kinetics of GIRK channel deactivation. Neuro2A cells endogenously expressing RGS7⅐G␤5 complexes were transiently transfected with GABA B receptors, GIRK2c, and either GFP as a control or GFP-tagged forms of wild type R7BP or R7BP-GG. Analysis of whole-cell GIRK currents upon application and subsequent washout of baclofen indicated that, in the absence of HDFP, palmitoylated and geranylgeranylated forms of GFP-R7BP were functionally equivalent as indicated by GIRK deactivation kinetics relative to GFP controls (Fig. 4) . However, although GIRK channel deactivation kinetics in cells expressing wild type GFP-R7BP was sensitive to HDFP, they were resistant to HDFP in cells expressing GFP-R7BP-GG (Fig. 4) . These and the preceding results therefore provided three independent lines of evidence that HDFP affects GIRK channel deactivation kinetics specifically by inhibiting palmitate turnover on R7BP.
Serine Hydrolases Other Than or in Addition to APT1 and APT2 Depalmitoylate R7BP-APT1 is the only serine hydrolase shown to date that depalmitoylates proteins oriented toward the cell cytoplasm (10), suggesting that this enzyme and/or its close relative APT2 potentially depalmitoylate R7BP. We tested this hypothesis by knocking down APT1 and APT2 and/or inhibiting them with a potent, reversible inhibitor specific for each enzyme (compounds 21 and 1, respectively (33)). Efficient knockdown or inhibition of APT1 and -2 was achieved but failed to affect R7BP localization (Fig. 5, A-D) . Moreover, combining knockdown of APT1 and -2 with inhibitors of both enzymes did not impair R7BP depalmitoylation (Fig. 5E ). These results indicated that serine hydrolases other than or in addition to APT1 and APT2 in neuronal cells depalmitoylate R7BP. 
DISCUSSION
Palmitate turnover is well established as a widespread biochemical process because hundreds of proteins, even in single cell types (19, 31, (41) (42) (43) (44) , are palmitoylated, and many proteins are dynamically palmitoylated or change palmitoylation status in response to cell activation or disease (11, 19, 22) . However, whether palmitate turnover is essential for protein function or regulation remains poorly understood. As discussed below, our studies of R7BP establish a novel, essential function for palmitate turnover for regulating neuronal G protein-coupled receptor signaling and indicate that depalmitoylation in neuronal cells involves serine hydrolases other than or in addition to APT1.
We have found that palmitate turnover on R7BP is required for timely deactivation of G i/o -gated GIRK channels by R7 RGS⅐G␤5 complexes in neuronal cells. Palmitate turnover is required to accumulate R7BP on the plasma membrane, similar to H/N-Ras (7) . Blunting palmitate turnover redistributes R7BP to endomembranes, thereby removing R7BPbound R7-RGS⅐G␤5 complexes from GIRK channels at the plasma membrane. Because R7 RGS⅐G␤5 complexes are GTPase-activating proteins for G i/o ␣ subunits docked on GIRK channels, this redistribution process slows the rate of G i/o ␣ deactivation and consequent channel closure. Like H/N-Ras, stably palmitoylated R7BP may translocate by diffusion from the plasma membrane to endomembranes (21) . Conversely, R7BP undergoing palmitate turnover could be utilized as a substrate for endomembrane-localized palmitoyltransferases that facilitate its subsequent anterograde transport and steady state localization at the plasma membrane. Cycles of depalmitoylation and repalmitoylation of R7BP also may occur locally at the plasma membrane, similar to PSD-95 (18) . Indeed, both R7BP and PSD-95 are palmitoylated by DHHC2 (18, 28) , which localizes to endomembranes and the plasma membrane.
GIRK channel regulation by dynamic palmitoylation of R7BP may have important physiological functions. By hyperpolarizing neurons, GIRK channels provide a principal mechanism for inhibitory modulation of synaptic transmission by scores of G i/o -coupled receptors and have been implicated in neurological disorders, including chronic pain, epilepsy, Parkinson disease, and Down syndrome (45) . By impairing G i/o deactivation, genetic ablation of R7BP augments GIRK activity and enhances the antinociceptive effects of morphine (26) , which are evoked by G i/o -coupled -opioid receptors and GIRK channels (46) . By impairing R7BP localization and function at the plasma membrane, depalmitoylation inhibitors therefore may provide a means of enhancing morphine action in chronic pain or augmenting GIRK activity in neurological disorders.
We have found that R7BP palmitoylation and trafficking are regulated strikingly by G i/o signaling. Interruption of G i/o sig- FEBRUARY 28, 2014 • VOLUME 289 • NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 6255 naling in neurons leads to accumulation of fully depalmitoylated R7BP in the nucleus (28) , whereas sustained G i/o signaling inhibits R7BP depalmitoylation and promotes endomembrane localization. Regulation of palmitate turnover on R7BP therefore may determine whether R7 RGS⅐G␤5 complexes control G i/o signaling at the plasma membrane or intracellular compartments or potentially transduce signals between compartments.
Palmitate Turnover Regulates GPCR-GIRK Signaling
The serine hydrolases that depalmitoylate R7BP remain to be identified. Because knockdown and inhibition of the established acylprotein thioesterase APT1 and its relative APT2 did not affect R7BP localization or depalmitoylation in neuronal cells, these enzymes may be uninvolved. Alternatively, APT1 and/or APT2 could function redundantly with other serine hydrolases to depalmitoylate R7BP. Once the relevant acylprotein thioesterases have been identified, the mechanisms that regulate palmitate turnover on R7BP can be investigated.
In conclusion, approaches analogous to those used by us and others (7, 47) should enable investigators to define the functions of palmitate turnover on specific proteins in a variety of biological processes. Such knowledge promises to reveal cellular and disease processes that potentially could be modulated by inhibitors of palmitate attachment or removal.
